Acceleron Pharma (XLRN) And Celgene (CELG) Announce Positive Clinical Results

Acceleron Pharma IncĀ (NASDAQ: XLRN) and Celgene CorporationĀ (NASDAQ: CELG) are both having a pretty strong start to the trading session this morning, and for good reason. The companies jointly announced positive clinical data from a Phase III trial. Of course, the news excited investors, leading to gains. Today, we’ll talk about: The clinical results; what we’re … Read more

ITUS Corp (ITUS) Stock: A Disruptive Force In Cancer Diagnostics And Immunotherapy

Cancer is a devastating illness that affects a large population of patients in the United States. In fact, it is estimated by the National Cancer Institute that in the year 2018 alone, 1.73535 million patients will be diagnosed with cancer and 609,640 Americans will succumb to the ailment. However, thanks to incredible advances in the … Read more

Celgene (CELG) Stock: Falls Hard On Regulatory Update

Celgene CorporationĀ (NASDAQ: CELG) is having an incredibly rough start to the trading session in the pre-market hours, and for good reason. The company announced a regulatory update, and the news was far from positive. Of course, this led to fear, sending the stock tumbling downward. Today, we’ll talk about the news, what we’re seeing from … Read more

Celgene Corporation (CELG) Stock: Takeover Chatter Hits The Wire

Celgene Corporation (NASDAQ: CELG) is up slightly on the day. However, that movement could change at any moment following the circulation of rumors that are hitting the feeds as we speak. Today, we’ll talk about what we’re seeing from the stock, rumors that are breaking, and what we’ll be watching for with regard to CELG … Read more

Celgene (CELG) Stock: Gaining On Agreement With Lannett Company (LCI)

Celgene Corporation (NASDAQ: CELG) Lannett Company (NYSE: LCI) Celgene Corporation is off to an incredibly strong start to the trading session this morning and for good reason. The company announced that it has entered into an agreement with Lannett Company, which is causing excitement among investors and sending the stock toward the top. Today, we’ll … Read more

Celgene (CELG) Stock: Taking A Dive On Updated Guidance

Celgene Corporation (NASDAQ: CELG) is having an overwhelmingly rough start to the trading session today, and for good reason. The company released long-term guidance that proved to be a major concern among investors, who are ultimately sending the stock tumbling. As is normally the case, our partners at Trade Ideas were the first to alert … Read more

Celgene Corporation (CELG) Stock: Flying High On Acquisition Rumor

Celgene Corporation (NASDAQ: CELG) Celgene Corporation is having an incredibly strong start to the trading week today. While the stock started off today’s trading session on a business-as-usual note, things changed minutes ago as the stock skyrocketed toward the top. Below, we’ll talk about what we’re seeing from the stock, why, and what we’ll be … Read more

Celgene (CELG) Declines On Earnings | Get Ready For A Strong Recovery!

Celgene Corporation (NASDAQ: CELG) As expected, Celgene reported earnings for the third quarter. Also as many expected, the company beat expectations with regard to EPS. However, the stock is declining in pre-market trading; this has, unfortunately, become the expectation for CELG. Today, we’ll talk about earnings, what we’re seeing in the market as a result, … Read more